Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTX

Pernix Therapeutics (PTX) Stock Price, News & Analysis

Pernix Therapeutics logo

About Pernix Therapeutics Stock (NASDAQ:PTX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.03
$0.21
52-Week Range
N/A
Volume
16,105 shs
Average Volume
3.04 million shs
Market Capitalization
$419 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pernix Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PTX Stock News Headlines

PANXD PTX Metals Inc.
Bicycle Therapeutics PLC ADR BCYC
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
Prescient Therapeutics Ltd
Pernix Therapeutics Holdings Inc (PTX)
See More Headlines

PTX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Pernix Therapeutics investors own include PIMCO High Income Fund (PHK), Synergy Pharmaceuticals (SGYP), Investors Bancorp (ISBC), Novavax (NVAX), Gevo (GEVO), Amira Nature Foods (ANFI) and Argos Therapeutics (ARGSQ).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:PTX
CIK
1024126
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$77.14 million
Net Margins
-59.70%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-37.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.08
Quick Ratio
0.92

Sales & Book Value

Annual Sales
$146.07 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($14.77) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,510,000
Free Float
N/A
Market Cap
$419 thousand
Optionable
Optionable
Beta
1.20
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:PTX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners